oktober 10, 2019
SAN DIEGO and COPENHAGEN, Denmark, Oct. 9, 2019 /PRNewswire/ — AFYX Therapeutics, a clinical stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced results from a Phase 1 clinical proof of concept study evaluating the use of the Rivelin® bio-adhesive patch in patients with vulvar lichen sclerosus (VLS), a painful genital skin condition that affects up to 3% of post-menopausal women....


Lundbeckfonden tildeler rekordstort antal fellowships
6. november 2019
Feberkramper hos småbørn undersøges til bunds
1. november 2019
Lundbeckfonden støtter 20 erfarne forskere med 100 mio. kr.
24. oktober 2019


Lundbeckfonden Ventures

Lundbeckfonden Emerge